XYZ Biotech: A Fictional Business Development Case Utilizing Quantitative Tools to Evaluate a New Antibody-Drug-Conjugate Opportunity for Metastatic Breast Cancer. (2023). American Journal of Management, 23(5). https://articlearchives.co/index.php/AJM/article/view/6109